Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $1.72 Million - $2.48 Million
-41,404 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $974 - $1,524
-27 Reduced 0.07%
41,404 $2.23 Million
Q3 2020

Nov 13, 2020

BUY
$33.26 - $40.48 $7,017 - $8,541
211 Added 0.51%
41,431 $1.53 Million
Q2 2020

Aug 14, 2020

BUY
$24.21 - $31.02 $117,515 - $150,571
4,854 Added 13.35%
41,220 $1.28 Million
Q4 2019

Feb 19, 2020

BUY
$18.96 - $29.84 $20,856 - $32,824
1,100 Added 3.12%
36,366 $1.06 Million
Q3 2019

Nov 05, 2019

BUY
$19.12 - $26.24 $20,305 - $27,866
1,062 Added 3.1%
35,266 $674,000
Q2 2019

Aug 12, 2019

BUY
$19.57 - $24.1 $75,011 - $92,375
3,833 Added 12.62%
34,204 $750,000
Q1 2019

May 07, 2019

BUY
$12.14 - $20.46 $368,703 - $621,390
30,371 New
30,371 $621,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.13B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.